JPWO2021070934A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021070934A5
JPWO2021070934A5 JP2021551720A JP2021551720A JPWO2021070934A5 JP WO2021070934 A5 JPWO2021070934 A5 JP WO2021070934A5 JP 2021551720 A JP2021551720 A JP 2021551720A JP 2021551720 A JP2021551720 A JP 2021551720A JP WO2021070934 A5 JPWO2021070934 A5 JP WO2021070934A5
Authority
JP
Japan
Prior art keywords
molecule
binds
subject
component
bc2lcn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021551720A
Other languages
English (en)
Japanese (ja)
Other versions
JP7656829B2 (ja
JPWO2021070934A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/038300 external-priority patent/WO2021070934A1/ja
Publication of JPWO2021070934A1 publication Critical patent/JPWO2021070934A1/ja
Publication of JPWO2021070934A5 publication Critical patent/JPWO2021070934A5/ja
Application granted granted Critical
Publication of JP7656829B2 publication Critical patent/JP7656829B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021551720A 2019-10-11 2020-10-09 がんの検査方法 Active JP7656829B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019187197 2019-10-11
JP2019187197 2019-10-11
PCT/JP2020/038300 WO2021070934A1 (ja) 2019-10-11 2020-10-09 がんの検査方法

Publications (3)

Publication Number Publication Date
JPWO2021070934A1 JPWO2021070934A1 (cg-RX-API-DMAC7.html) 2021-04-15
JPWO2021070934A5 true JPWO2021070934A5 (cg-RX-API-DMAC7.html) 2023-10-13
JP7656829B2 JP7656829B2 (ja) 2025-04-04

Family

ID=75438180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021551720A Active JP7656829B2 (ja) 2019-10-11 2020-10-09 がんの検査方法

Country Status (6)

Country Link
US (1) US12618842B2 (cg-RX-API-DMAC7.html)
EP (1) EP4043881A4 (cg-RX-API-DMAC7.html)
JP (1) JP7656829B2 (cg-RX-API-DMAC7.html)
KR (1) KR102896955B1 (cg-RX-API-DMAC7.html)
CN (1) CN114556101B (cg-RX-API-DMAC7.html)
WO (1) WO2021070934A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022182394A (ja) * 2021-05-28 2022-12-08 独立行政法人国立病院機構 抗原固相化デバイス
WO2025187809A1 (ja) * 2024-03-08 2025-09-12 富士フイルム株式会社 検出対象物質を免疫学的に検出する方法、非特異反応を抑制する方法、フコース含有組成物、および試薬キット

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
JP5977743B2 (ja) 2011-06-15 2016-08-24 三洋化成工業株式会社 磁性シリカ粒子を用いた測定方法及び該測定方法用試薬
WO2013172105A1 (ja) * 2012-05-18 2013-11-21 日東紡績株式会社 膵臓癌を検出するためのマーカー
WO2014126146A1 (ja) 2013-02-14 2014-08-21 独立行政法人産業技術総合研究所 未分化細胞除去方法
US20180250360A1 (en) 2015-10-05 2018-09-06 National Institute Of Advanced Industrial Science And Technology Method for detecting cancer cells, reagent for introducing substance into cancer cells, and composition for treating cancer
US11078254B2 (en) 2017-04-11 2021-08-03 National Institute Of Advanced Industrial Science And Technology Method for immobilizing lectin
JP7386647B2 (ja) 2018-08-13 2023-11-27 東ソー株式会社 糖鎖への親和性が向上したフコース結合性タンパク質、およびその製造方法

Similar Documents

Publication Publication Date Title
Van Gool et al. Analytical techniques for multiplex analysis of protein biomarkers
Wang et al. Emerging salivary biomarkers by mass spectrometry
KR20180123978A (ko) 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도
Kruse et al. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
KR101788414B1 (ko) 간암 조기 진단용 바이오마커 및 그 용도
Pedersen et al. Quantification of multiple elements in dried blood spot samples
Kiernan et al. Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay
JP2023545017A5 (cg-RX-API-DMAC7.html)
WO2005003767A3 (en) Elemental analysis of tagged biologically active materials
WO2005027733A2 (en) Biological markers for diagnosing multiple sclerosis
Krcmova et al. Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC
Ma et al. Liquid chromatography-tandem mass spectrometry in clinical laboratory protein measurement
WO2021107154A1 (ja) アルツハイマー型認知症又は軽度認知障害の診断を補助する方法、バイオマーカー、試薬キット及び装置
US20150203892A1 (en) Method for determining breast cancer
Roy et al. Differential expression profiling of serum proteins and metabolites for biomarker discovery
Wijeyesekera et al. Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study
Jahanban-Esfahlan et al. Optical sensing of albumin in human serum and urine—A historical review of the transition from classical dye-binding assays to advanced technologies
Herwig et al. Sensitive detection of C-reactive protein in serum by immunoprecipitation–microchip capillary gel electrophoresis
Sauer et al. Critical role of the sample matrix in a point-of-care protein chip for sepsis
Georgiadis et al. Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo [a] pyrene and other polycyclic aromatic hydrocarbons
JP2024537879A (ja) 癌診断用バイオマーカー及びその用途
JP2023548110A5 (cg-RX-API-DMAC7.html)
Sirén et al. Direct monitoring of glycohemoglobin A1c in the blood samples of diabetic patients by capillary electrophoresis: Comparison with an immunoassay method
Balog et al. Novel automated biomarker discovery work flow for urinary peptidomics
KR101552011B1 (ko) 리소포스파티딜콜린 및 호모시스테인산을 포함하는 난소암 진단용 조성물 및 이를 사용하여 난소암을 진단하는 방법